Cipla Limited (Mumbai, India). 2024 revenue ~$3.0B. Respiratory generics: Seroflo, Foracort. APIs across 80+ markets. 2K+ products. HIV/AIDS treatment pioneer. 47 manufacturing facilities globally.
12:49:42 AM · Jul 9, 2026
Sign in to reply and join the conversation.